Unlocking more blood cancer insight with NGS

63rd ASH Annual Meeting and Exposition

At Thermo Fisher Scientific, we have developed advanced
next-generation sequencing solutions to address key challenges in the molecular analysis of hematologic malignancies.

Join us during the 63nd ASH Annual Meeting and Exposition to learn how we can help simplify your path to answers in the study of myeloid and lymphoid cancers.

See us at booth 1532

Featured Poster Presentations

Immune Repertoire Analysis of Multiple Myeloma Research Samples Using NGS

Characterization of Multiple B Cell Receptors in a Single Reaction

Cropped- Image

Presenter: Geoffrey Lowman, PhD

Senior Staff Scientist - Molecular Biology
Thermo Fisher Scientific

Date: Saturday, December 11, 2021: 5:30 PM-7:30 PM
Location: Hall B5 (Georgia World Congress Center)

Read Abstract >
View Poster >

Fully Automated Workflows Quantify and Report Key T-Cell and B-Cell Receptor Biomarkers Relevant to Immuno-Oncology and Heme-Oncology Research

sarda

Presenter: Shrutii Sarda

Staff Scientist, Bioinformatics
Thermo Fisher Scientific

Date: Monday, December 13, 2021: 6:00 PM-8:00 PM
Location: Hall B5 (Georgia World Congress Center)

Read Abstract >
View Poster >

Development of an automated genomic profiling assay for myeloid malignancies

Jiajie

Presenter: Dr. Jiajie Huang

Senior Bioinformatics Scientist
Thermo Fisher Scientific

Published and presented at the AMP 2021

View Poster >

Featured Solutions

Oncomine Myeloid Assay GX v2

The first myeloid genomic profiling solution that can deliver an NGS report, covering all key DNA and RNA targets, in as little as one day on the Ion Torrent Genexus System.

Oncomine Pan-Clonality Assays

Advanced NGS solutions that can sequence multiple B- and T-cell receptor targets in a single reaction for highly sensitive and specific clone detection.

Explore our full hemato-oncology product portfolio

Attend Upcoming Webinar

Rapid Next-Generation Sequencing for the Study of Acute Myeloid Leukemia

Speaker:

Dr. Diana Morlote

University of Alabama at Birmingham

During this presentation, Dr. Diana Morlote, assistant professor of pathology at the University of Alabama at Birmingham, will discuss the recent implementation of a rapid, automated next-generation sequencing (NGS) assay in her research laboratory for genomic profiling of Acute Myeloid Leukemia (AML) and other related hematological disorders. The data collected from several cases using the Oncomine Myeloid Assay GX v2 by Thermo Fisher Scientific will be presented. Analytical performance will be discussed for various key mutations detected using DNA inputs. Morlote will describe how this solution addresses key challenges with molecular analysis of AML and other related malignancies. This research furthers our understanding of malignant hematological disorders and may lead to better care in the future.

Morlote-Diana-webinar-feature

Date: Thursday, January 27, 2022
Time: 11:00 AM Eastern Standard Time

Explore Genexus

One complete NGS system

The Ion Torrent™ Genexus™ System is the first turnkey next-generation sequencing (NGS) solution that automates the end-to-end workflow from the biological specimen all the way to the final report and delivers results in as little as a single day.*